Oragenics (OGEN) FCF Margin (2010 - 2023)
Oragenics' (OGEN) quarterly FCF Margin came in at 20131.42% in Q3 2023, down 1570021.0% YoY from N/an in Q3 2022, and down 2.84% on a QoQ basis from 19574.78% in Q2 2023.
Oragenics (OGEN) FCF Margin (2010 - 2023) Analysis & Trends
Oragenics (OGEN) has 7 years of FCF Margin data on file, last reported at 20131.42% in Q3 2023.
- Quarterly FCF Margin fell 1570021.0% year-over-year to 20131.42% in Q3 2023, while the trailing twelve-month figure through Dec 2023 was 19363.34% (down 768764.0% YoY) and the FY2023 annual result came in at 19363.34%, down 768764.0% from the prior year.
- FCF Margin slipped to 20131.42% in Q3 2023, from 19574.78% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 4431.21% in Q3 2022 to a low of 37950.0% in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -388.28% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 25.68% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 22.62% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 41.07% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -22.35% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 70.82% |
| 10 | Oragenics | 2.31 Mn | 2.31 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -20,131.42% |
| Jun 30, 2023 | -19,574.78% |
| Mar 31, 2023 | -12,386.60% |
| Sep 30, 2022 | -4,431.21% |
| Jun 30, 2022 | -11,130.94% |
| Mar 31, 2022 | -37,950.00% |
| Dec 31, 2014 | -576.53% |
| Sep 30, 2014 | -546.81% |
| Jun 30, 2014 | -558.43% |
| Mar 31, 2014 | -746.83% |
| Dec 31, 2013 | -280.71% |
| Sep 30, 2013 | -779.61% |
| Jun 30, 2013 | -1,192.98% |
| Mar 31, 2013 | -896.17% |
| Dec 31, 2012 | -404.31% |
| Sep 30, 2012 | -445.79% |
| Jun 30, 2012 | -448.46% |
| Mar 31, 2012 | -300.40% |
| Dec 31, 2011 | -350.80% |
| Sep 30, 2011 | -433.50% |